Drug Trial Radar · NCT00424190
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Last checked: Nov 19, 2026Latest source record: Mar 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
698
Actual
Start
Feb 2007
Primary completion
Nov 2007
Study completion Nov 2007
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jan 18, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.
Conditions
- Bacterial Infections
Interventions
IV Vancomycin plus IV AztreonamDrug
vancomycin at 1 g parenteral infused over 60 minutes followed by aztreonam 1 g infused over 60 minutes, every 12 hours, for 5 to 14 days.
CeftarolineDrug
600 mg parenteral infused over 60 minutes, every 12 hours for 5 to 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Cure Rate at Test of Cure (TOC) (MITT Population)Time frame: 8-15 days after the end of treatment
- Clinical Cure Rate of Ceftaroline Compared With That of Vancomycin Plus Aztreonam Treatment at TOC in the Clinically Evaluable (CE) PopulationTime frame: 8-15 days after last dose of study drug
Locations
52 sites in 11 countries. Site status is shown where the registry gives one.
Investigational Site
Dothan, Alabama
Investigational Site
Long Beach, California
Investigational Site
Los Angeles, California
Investigational Site
Sacramento, California
Investigational Site
Sacramento, California
Investigational Site
San Diego, California
Investigational Site
San Francisco, California
Investigational Site
Torrance, California
Investigational Site
Savannah, Georgia
Investigational Site
Naperville, Illinois
Investigational Site
Indianapolis, Indiana
Investigational Site
Shreveport, Louisiana
Investigational Site
Columbus, Ohio
Investigational Site
Landsdale, Pennsylvania
Investigational Site
Tacoma, Washington
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Investigational Site
Buenos Aires, Argentina
Invetigational Site
Buenos Aires, Argentina
Investigational Site
Córdoba, Argentina
Invetigational Site
Córdoba, Argentina
Investigational Site
Entre Ríos, Argentina
Investigational Site
Santa Fe, Argentina
Investigational Site
Curiuba-Parans, Brazil
Investigational Site
São Paulo, Brazil
Investigational Site
Santiago, Chile
Investigational Site
Viña del Mar, Chile
Investigational Site
Berlin, Germany
Investigational Site
Bochum, Germany
Investigational Site
Hanau, Germany
Investigational Site
Plauen, Germany
Investigational Site
Quedlinburg, Germany
Investigational Site
Chihuahua City, Mexico
Invetigational Site
Lima, Peru
Investigational Site
Bytom, Poland
Investigational Site
Krakow, Poland
Investigational Site
Lublin, Poland
Investigational Site
Sosnowiec, Poland
Investigational Site
Todz, Poland
Investigational Site
Bucharest, Romania
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.